Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - CASH & EQUIVALENTS
Cash & Equivalents NVO - Novo Nordisk A/S
14.4 B
LAST VALUE
15.87%
2 YEAR CAGR
-1.65%
5 YEAR CAGR
2.98%
10 YEAR CAGR